Antibiotic resistance in Pseudomonas aeruginosa: mechanisms and alternative therapeutic strategies

Антибиотикорезистентность Pseudomonas aeruginosa: механизмы и альтернативные терапевтические стратегии
Bernard R. Glick, Zhenyu Cheng, Zheng Pang, Renee Raudonis, Tong‐Jun Lin
2018-11-27

Pseudomonas aeruginosaalternative therapeutic strategiesantibiotic resistance mechanismsbiofilm-mediated resistancepersister cells
Pseudomonas aeruginosa is an opportunistic pathogen that is a leading cause of morbidity and mortality in cystic fibrosis patients and immunocompromised individuals. Eradication of P. aeruginosa has become increasingly difficult due to its remarkable capacity to resist antibiotics. Strains of Pseudomonas aeruginosa are known to utilize their high levels of intrinsic and acquired resistance mechanisms to counter most antibiotics. In addition, adaptive antibiotic resistance of P. aeruginosa is a recently characterized mechanism, which includes biofilm-mediated resistance and formation of multidrug-tolerant persister cells, and is responsible for recalcitrance and relapse of infections. The discovery and development of alternative therapeutic strategies that present novel avenues against P. aeruginosa infections are increasingly demanded and gaining more and more attention. Although mostly at the preclinical stages, many recent studies have reported several innovative therapeutic technologies that have demonstrated pronounced effectiveness in fighting against drug-resistant P. aeruginosa strains. This review highlights the mechanisms of antibiotic resistance in P. aeruginosa and discusses the current state of some novel therapeutic approaches for treatment of P. aeruginosa infections that can be further explored in clinical practice.
1
Biofilm-mediated resistance and multidrug-tolerant persister cells promote infection recalcitrance and relapse.
2
Its resistance reflects intrinsic, acquired, and adaptive mechanisms that collectively counter most antibiotics.
3
Novel therapeutic strategies have shown pronounced effectiveness against drug-resistant P. aeruginosa strains, although most remain at preclinical stages.
4
Pseudomonas aeruginosa causes substantial morbidity and mortality, particularly in cystic fibrosis patients and immunocompromised individuals.
5
The review identifies alternative treatment approaches that warrant further investigation and potential translation into clinical practice.

Pseudomonas aeruginosa infections and their drug-resistant strains

Antibiotic resistance mechanisms, including intrinsic, acquired, and adaptive resistance, and alternative therapeutic strategies for these infections

Publication Details
Publication Date
2018-11-27
Journal
Publisher
ISSN
Cited by
2582
Access Type
Author Information
Authors
Bernard R. Glick
Zhenyu Cheng
Zheng Pang
Renee Raudonis
Tong‐Jun Lin
Explore further
Open the scid.ai AI chat with a ready-made request: it will find papers on a similar topic and help build a literature review.
Find similar papers in the chat →
Make a presentation
100%